| Literature DB >> 35651754 |
Jingrui Song1,2,3, Jin Chao1,2,3, Xiaohong Hu2,4, Xin Wen1,2,3, Cairong Ding1,2,3, Dan Li2,4, Ding Zhang1,2,3,5, Shanshan Han1,2,3, Xiang Yu1,2,3, Bo Yan6, Zhu Jin2,4, Yinhong Song1,2,3, Jacqueline Gonzales7, Laura E Via7,8, Lu Zhang9, Decheng Wang1,2,3.
Abstract
Tumor necrosis factor alpha (TNF-α) is a crucial factor in the control of Mycobacterium tuberculosis (Mtb) infection. Pathogenic mycobacteria can inhibit and/or regulate host cell TNF-α production in a variety of ways to evade antituberculosis (anti-TB) immunity as well as facilitate immune escape. However, the mechanisms by which TNF-α expression in host cells is modulated to the benefit of mycobacteria is still an interesting topic and needs further study. Here, we report that macrophages infected with Mycobacterium marinum (Mm)-a close relative of Mtb-upregulated the expression of E3 ubiquitin ligase FBXW7. Specific silencing FBXW7 with small interfering RNA (siRNA) significantly elevates TNF-α expression and eventually promotes the elimination of intracellular bacteria. In turn, overexpression of FBXW7 in Raw264.7 macrophages markedly decreased TNF-α production. Furthermore, partial inhibition of FBXW7 in an Mm-infected murine model significantly reduced TNF-α tissue content, alleviated tissue damage as well as reduced the bacterial load of mouse tails. Finally, FBXW7 could decrease TNF-α in a K63-linked ubiquitin signaling dependent manner. Taken together, our study uncovered a previously unknown role of FBXW7 in regulating TNF-α dynamics during mycobacterial infection, which provides new insights into understanding the role of FBXW7 in anti-tuberculosis immunity and its related clinical significance.Entities:
Keywords: FBXW7; TNF-α; granuloma; mycobacteria; ubiquitination
Mesh:
Substances:
Year: 2022 PMID: 35651754 PMCID: PMC9149249 DOI: 10.3389/fcimb.2022.851197
Source DB: PubMed Journal: Front Cell Infect Microbiol ISSN: 2235-2988 Impact factor: 6.073
Figure 1Design and protocol for the animal experiment. Sixty-six C57BL/6 mice were divided randomly into three groups. Twenty-two animals were administered PBS by i.v. to the tail vein. Twenty-two were injected with WT Mm while another twenty-two received △PDIM. After 7 days, the animals were divided randomly into two groups of eleven animals each. These groups were administered SB-216763 or PBS by i.p. every other day until sacrifice at 21 days. On days 7 and 14, three mice for each group were sacrificed, and then tails from them were sampled for detection of bacterial load and Western blot assays. On day 21, all the mice were sacrificed for assays. IHC, Immunohistochemistry staining.
Figure 2FBXW7 is differently expressed in macrophages after WT Mm infection and in the lung tissues of hosts with Mtb infection. (A) mRNA expression of FBXW7 in macrophages after Mm infection (MOI of 5) over 12 hours (n=3) was detected by qRT-PCR. Increased expression of FBXW7 mRNA was observed at 4 and 8 h in cells post infection with WT Mm relative to MOCK (P < 0.01). (B) protein expression of FBXW7 in macrophages after WT Mm infection (MOI of 5) over 0.5 to 4 h relative to ß-actin. **P < 0.01 (C) Representative images of macrophages stained for FBXW7 (green) and the Mm marker tdTomato (red). Nuclei were counterstained with DAPI to identify the cellular location of FBXW7. Scale bar, 10 μm. (D) Representative immunohistochemical images of FBXW7 (brown precipitate) in the granulomas of lung samples from experimentally Mtb-infected C57BL/6J mouse and NZW rabbit and two natural Mtb-infected patients. Nuclei are counterstained with hematoxylin. Scale bar, 200 μm. The experiments were performed three times with similar results.
Figure 3FBXW7 influences the expression of inflammatory mediators in Mm infection. (A, B) Raw264.7 cells were transfected with FBXW7 mimic (siRNA-Control) or FBXW7 inhibitor (siRNA-FBXW7) for 24 h, which was followed by infection with Mm at 5 MOI for 4 h or mock infection treatment. The expression of pro- and anti-inflammatory mediators were detected by qRT-PCR (A) and Western blot (B). TGF-ß and IL-10 mRNA expression were down-regulated by FBXW7 silencing in Mm infected cells. TNF-α mRNA and protein and iNOS mRNA expression were up-regulated by FBXW7 silencing in Mm infected cells. (C) Raw264.7 cells were transfected with PCDNA3.1 or PCDNA3.1_FBXW7 for 24 h, which was followed by infection with wild type Mm or △PDIM strains at 5 MOI for 4 h. The expression of TNF-α was detected by Western blot. β-actin was used as an internal control. All the data in the histograms represent the mean ± standard deviation SD. *P < 0.05 and **P < 0.01. All the experiments were repeated three times with similar results.
Figure 4FBXW7 influences the expression and location of NF-κBp65 in Mm-infected macrophages. (A, B) Representative immunofluorescence images of macrophages stained for the FBXW7 (green, FITC-labeled second antibody) and the NF-κBp65 (red or purple, Alexa Fluor 647- or Alexa Fluor Plus 405- labeled the second antibody). Nuclei were counterstained with DAPI to identify the cellular location of FBXW7 and NF-κBp65. Scale bar, 10 μm. (C) the percentage of nuclear NF-κBp65 positive cells in the immunohistochemical images in (A, B). The averaged values represent the mean ± standard deviation (SD) (n = 3 per group). At least 200 total nuclei per well were counted, and the signal for nuclear p65 was quantified as the percentage of nuclei number (DAPI) merged with p65 divided by the total number of nuclei counted per well, n = 3 wells per condition. *P < 0.05 and **P < 0.01.
Figure 5Inhibition of FBXW7 by SB-216763 alleviated tail injury in mice following Mm infection. (A) Tails of WT Mm infected mice treated with vehicle or SB-216763 for 14 days. The area of all visible lesions on each tail was combined on the 21st day post-infection and graphed; the bars represent the mean ± standard deviation (SD) (n = 5 per group; 5 groups shown in legend). Significant differences between the WT and WT+SB-21676 are indicated (*P < 0.05; **P < 0.01); (B) Representative images of H&E staining of tail lesions. More lymphohistiocytic infiltrates were observed in the tail tissues infected with WT Mm compared to the PBS group, while these were somewhat alleviated when the mice were treated with SB-216763. Magnification = 4×. (C) Bacterial burden in the whole tail was quantified by enumeration of CFU at multiple time points post-infection. The averaged values represent the mean ± standard deviation (SD) (n = 3). (D) Representative immunohistochemical images of FBXW7 staining (brown precipitate) in the tail samples from mice treated as indicated. Nuclei are counterstained with hematoxylin. Scale bar, 500 μm. (E) The expression of TNF-α and TGF-β were detected by Western blot in the tail samples from mice at 14 and 21 days post-infection. β-actin was used as an internal control. *P < 0.05 and **P < 0.01.
Figure 6FBXW7 facilitates the degradation of TNF-α by K63-linked ubiquitylation. (A) Immunoblot of Raw264.7 cells co-transfected for 48 h with Myc-FBXW7, plus Flag-TNF-α, HA-ub and treated with MG132 before cell harvest; adding FBXW7 to the system significantly decreases TNF-α (P = 0.01) (B) Immunoblot of Raw264.7 cells co-transfected with Flag-TNF-α, Myc-FBXW7 along with Ha-Ub, the mutant ubiquitin Ha-K48R Ub or Ha-K63R Ub and treated with MG132 before cell harvest. Similarly, the addition of myc-FBXW7 and K48R mutant Ha-Ub reduced the expression of Flag-TNF-α significantly (P = 0.05). The experiments were performed three times with similar results. *P < 0.05 and **P < 0.01.